ES10750/ES/NIEHS NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2001	1
2002	3
2003	2
2004	1
2005	1
2006	2
2024	0

1

Nonsteroidal anti-inflammatory drugs and risk of Parkinson's disease.

Ton TG, Heckbert SR, Longstreth WT Jr, Rossing MA, Kukull WA, Franklin GM, Swanson PD, Smith-Weller T, Checkoway H. Ton TG, et al. Mov Disord. 2006 Jul;21(7):964-9. doi: 10.1002/mds.20856. Mov Disord. 2006. PMID: 16550541

2

Glutathione S-transferase M1, T1, and P1 polymorphisms and Parkinson's disease.

Kelada SN, Stapleton PL, Farin FM, Bammler TK, Eaton DL, Smith-Weller T, Franklin GM, Swanson PD, Longstreth WT Jr, Checkoway H. Kelada SN, et al. Neurosci Lett. 2003 Jan 30;337(1):5-8. doi: 10.1016/s0304-3940(02)01286-7. Neurosci Lett. 2003. PMID: 12524158

3

Genetic polymorphisms of microsomal and soluble epoxide hydrolase and the risk of Parkinson's disease.

Farin FM, Janssen P, Quigley S, Abbott D, Hassett C, Smith-Weller T, Franklin GM, Swanson PD, Longstreth WT Jr, Omiecinski CJ, Checkoway H. Farin FM, et al. Pharmacogenetics. 2001 Nov;11(8):703-8. doi: 10.1097/00008571-200111000-00009. Pharmacogenetics. 2001. PMID: 11692079

4

No associations between Parkinson's disease and polymorphisms of the quinone oxidoreductase (NQO1, NQO2) genes.

Okada S, Farin FM, Stapleton P, Viernes H, Quigley SD, Powers KM, Smith-Weller T, Franklin GM, Longstreth WT, Swanson PD, Checkoway H. Okada S, et al. Neurosci Lett. 2005 Mar 3;375(3):178-80. doi: 10.1016/j.neulet.2004.11.009. Epub 2004 Dec 10. Neurosci Lett. 2005. PMID: 15694256

5

Collaborative analysis of alpha-synuclein gene promoter variability and Parkinson disease.

Maraganore DM, de Andrade M, Elbaz A, Farrer MJ, Ioannidis JP, Krüger R, Rocca WA, Schneider NK, Lesnick TG, Lincoln SJ, Hulihan MM, Aasly JO, Ashizawa T, Chartier-Harlin MC, Checkoway H, Ferrarese C, Hadjigeorgiou G, Hattori N, Kawakami H, Lambert JC, Lynch T, Mellick GD, Papapetropoulos S, Parsian A, Quattrone A, Riess O, Tan EK, Van Broeckhoven C; Genetic Epidemiology of Parkinson's Disease (GEO-PD) Consortium. Maraganore DM, et al. JAMA. 2006 Aug 9;296(6):661-70. doi: 10.1001/jama.296.6.661. JAMA. 2006. PMID: 16896109

6

Parkinson's disease risks associated with dietary iron, manganese, and other nutrient intakes.

Powers KM, Smith-Weller T, Franklin GM, Longstreth WT Jr, Swanson PD, Checkoway H. Powers KM, et al. Neurology. 2003 Jun 10;60(11):1761-6. doi: 10.1212/01.wnl.0000068021.13945.7f. Neurology. 2003. PMID: 12796527

7

Parkinson's disease risks associated with cigarette smoking, alcohol consumption, and caffeine intake.

Checkoway H, Powers K, Smith-Weller T, Franklin GM, Longstreth WT Jr, Swanson PD. Checkoway H, et al. Am J Epidemiol. 2002 Apr 15;155(8):732-8. doi: 10.1093/aje/155.8.732. Am J Epidemiol. 2002. PMID: 11943691

8

MAOB intron 13 and COMT codon 158 polymorphisms, cigarette smoking, and the risk of PD.

Hernán MA, Checkoway H, O'Brien R, Costa-Mallen P, De Vivo I, Colditz GA, Hunter DJ, Kelsey KT, Ascherio A. Hernán MA, et al. Neurology. 2002 May 14;58(9):1381-7. doi: 10.1212/wnl.58.9.1381. Neurology. 2002. PMID: 12011284

9

Gender difference in the interaction of smoking and monoamine oxidase B intron 13 genotype in Parkinson's disease.

Kelada SN, Costa-Mallen P, Costa LG, Smith-Weller T, Franklin GM, Swanson PD, Longstreth WT Jr, Checkoway H. Kelada SN, et al. Neurotoxicology. 2002 Oct;23(4-5):515-9. doi: 10.1016/s0161-813x(02)00061-x. Neurotoxicology. 2002. PMID: 12428723 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

9 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Results by year